Evidence map›Paper›PMID 30014296›Full record

ReviewPathology oncology research : POR2019

Research Progresses in Cancer Stem Cells of Three Common Fertility-Related Female Malignancies.

Xi-Ping Zhang, Qi-Hui Cheng, Hong-Jian Yang, En-Qi Qiao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pathology oncology research : POR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xi-Ping ZhangDepartment of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang, Province, People's Republic of China. zxp99688@sina.com.ORCID http://orcid.org/0000-0002-3556-9681
Qi-Hui ChengDepartment of Obstetrics and Gynecology, Hangzhou First People's Hospital, Province, Zhejiang, 310006, Hangzhou, China.
Hong-Jian YangDepartment of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang, Province, People's Republic of China.
En-Qi QiaoDepartment of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang, Province, People's Republic of China.
Zhejiang Cancer Hospital · CNHangzhou First People's Hospital · CN

Funding

This study was supported by a foundation for the "1022 first level of innovative talents of Zhejiang Cancer Hospital, China (grant number.2013102202) 2013102202
6 · The paper itself

Abstract

With abilities to renew themselves and lead to heterogeneity of tumors, cancer stem cells (CSCs) are similar to stem cells. As three leading causes of death that endanger women's health, breast cancer, ovarian cancer and cervical cancer are characterized by high degree of malignancy, metastasis and recurrence. Associated with women's fertility, these three malignancies are common and representative among females. These years, research findings have suggested that CSCs are closely connected with many cancers (including aforementioned three malignancies) and several processes of tumors such as their genesis and development. CSCs have become great concerns for current cancer treatment and interventions. This paper does not only summarize roles of CSCs in genesis, development, drug resistance, metastasis and recurrence of breast cancer, ovarian cancer and cervical cancer, but also proposes potential methods of treatment and intervention, in hope of inspiring readers and researchers.

Indexed as

AnimalsFemaleFertilityHumansNeoplasm MetastasisNeoplasm Recurrence, LocalNeoplastic Stem CellsBreast CancerCancer stem cellsCervical CancerFemaleMalignant tumorsOvarian Cancer

Identifiers

PMID30014296
OpenAlexW2882976999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.